Negar Mashoori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Negar Mashoori has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Ramesh Omranipour
Imam Khomeini Hospital, Tehran University of Medical Sciences
3 shared publications- Abbas Mirzapour
Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication Abdolali Assarian
Breast Surgery Unit, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationAh Rabani
Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Ahmad Elahi
Breast Disease Research Center Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Ahmad Kaviani
Department of Surgery, University of Montreal, Canada
1 shared publication
Latest Publications
- Open Access
- 15 May 2022
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 9 (3-SI) , 293-300
Idiopathic Granulomatous Mastitis; Radio-pathologic findings and Grading based on Clinical Presentation and treatment outcome in 224 patients
Background: Idiopathic granulomatous mastitis (IGM) is a rare inflammatory disease of the breast with unknown etiology. Clinico-radiologic findings can mimic breast cancer. Further pathologic evaluation to rule out malignancy is mandatory. Recognizing the severity of the disease is crucial to choosing the most effective therapeutic modality. The aim of this study is to evaluate clinical and radio-pathologic features of IGM, and the treatment outcome in a large series of IGM patients in Iran.Methods: The retrospective charts of 243 patients suspicious of IGM, between December 2007 and September 2017 were reviewed. Patients with confirmed diagnosis of IGM were classified into four grades of severity. Demographic information, clinical and radio-pathologic findings, severity and treatment outcomes were collected.Results: Overall, 224 patients were confirmed to have IGM. Breast mass and erythema were the most common clinical findings. Mammographic findings mimicked malignancy in 34%. Lobulo-centric non-caseating granulomas were the most common pathologic finding. Also, 61.5% of the patients had mild to moderate symptoms and 49.5% of them recovered completely by observation. In addition, 53 (25.9%) patients had severe symptoms and 30.8% of them were resistant to treatment. Conclusion: IGM is a diagnostic challenge. Its diagnosis is based on exclusion and a close cooperation between the clinician, the radiologist and the pathologist. Mild to moderate cases can be managed conservatively; however, severe cases may need further aggressive medical or surgical treatments.
- 15 May 2022
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 9 (3-SI) , 293-300
Open AccessIdiopathic Granulomatous Mastitis; Radio-pathologic findings and Grading based on Clinical Presentation and treatment outcome in 224 patients
Background: Idiopathic granulomatous mastitis (IGM) is a rare inflammatory disease of the breast with unknown etiology. Clinico-radiologic findings can mimic breast cancer. Further pathologic evaluation to rule out malignancy is mandatory. Recognizing the severity of the disease is crucial to choosing the most effective therapeutic modality. The aim of this study is to evaluate clinical and radio-pathologic features of IGM, and the treatment outcome in a large series of IGM patients in Iran.Methods: The retrospective charts of 243 patients suspicious of IGM, between December 2007 and September 2017 were reviewed. Patients with confirmed diagnosis of IGM were classified into four grades of severity. Demographic information, clinical and radio-pathologic findings, severity and treatment outcomes were collected.Results: Overall, 224 patients were confirmed to have IGM. Breast mass and erythema were the most common clinical findings. Mammographic findings mimicked malignancy in 34%. Lobulo-centric non-caseating granulomas were the most common pathologic finding. Also, 61.5% of the patients had mild to moderate symptoms and 49.5% of them recovered completely by observation. In addition, 53 (25.9%) patients had severe symptoms and 30.8% of them were resistant to treatment. Conclusion: IGM is a diagnostic challenge. Its diagnosis is based on exclusion and a close cooperation between the clinician, the radiologist and the pathologist. Mild to moderate cases can be managed conservatively; however, severe cases may need further aggressive medical or surgical treatments.
- Open Access
- 17 April 2022
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 9 (3-SI) , 261-271
Global Distribution of Idiopathic Granulomatous Mastitis: A Scoping Review
Background: Idiopathic granulomatous mastitis (IGM) is a challenging exclusion diagnosis for breast lesions, manifested as benign, chronic inflammation of the breast tissue. Although some evidence suggest that IGM cases are not uniformly distributed worldwide, few investigations have specifically addressed this topic. This study aims to examine the distribution of IGM cases among countries and races/ethnicities based on reported cases.Methods: A review of studies with a report of at least one IGM patient published from 2011 to 2020 inclusive was conducted. The search was performed in MEDLINE, and citations were filtered in two stages by title/abstract and full text. Those cases with a positive growth of pathogens, male granulomatous mastitis and review articles were excluded.Results: Among 365 retrieved publications, 218 were finally included based on the inclusion and exclusion criteria, comprising 7161 patients from 34 different countries. Turkey, the United States, and China were the countries where the most publications (including case reports) originated. Considering the number of patients within papers, Turkey, Iran, and China were the pioneers. Conclusion: Based on the published literature, some populations seem to be more prone to IGM. Further investigations may reveal the genetic and environmental factors associated with this disease in different geographic areas.
- 17 April 2022
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 9 (3-SI) , 261-271
Open AccessGlobal Distribution of Idiopathic Granulomatous Mastitis: A Scoping Review
Background: Idiopathic granulomatous mastitis (IGM) is a challenging exclusion diagnosis for breast lesions, manifested as benign, chronic inflammation of the breast tissue. Although some evidence suggest that IGM cases are not uniformly distributed worldwide, few investigations have specifically addressed this topic. This study aims to examine the distribution of IGM cases among countries and races/ethnicities based on reported cases.Methods: A review of studies with a report of at least one IGM patient published from 2011 to 2020 inclusive was conducted. The search was performed in MEDLINE, and citations were filtered in two stages by title/abstract and full text. Those cases with a positive growth of pathogens, male granulomatous mastitis and review articles were excluded.Results: Among 365 retrieved publications, 218 were finally included based on the inclusion and exclusion criteria, comprising 7161 patients from 34 different countries. Turkey, the United States, and China were the countries where the most publications (including case reports) originated. Considering the number of patients within papers, Turkey, Iran, and China were the pioneers. Conclusion: Based on the published literature, some populations seem to be more prone to IGM. Further investigations may reveal the genetic and environmental factors associated with this disease in different geographic areas.
- Open Access
- 13 April 2022
- Published by Springer Nature in Research Square
Comparison of high- and low-dose prednisolone in the treatment of idiopathic granulomatous mastitis: a retrospective study
Background:There is no consensus regarding best treatment for Idiopathic granulomatous mastitis(IGM). Regarding the inflammatory entity of this disease, corticosteroids have been used with good results. However, prescribing lower dosages are more appealing, regarding their side effects. The aim of this study is to compare the response and recurrence rates in IGM patients treated with low dose and high dose prednisolone.Methods: Medical records of patients diagnosed with IGM in the Cancer Institute and Arash Women's Hospital hospital of Tehran University of Medical Sciences from November 2012 to December 2020 were evaluated retrospectively. Patients with first presentation of disease who had been treated with oral prednisolone were included, and were classified as low dose group(less than 25mg) and high dose group(equal or more than 25mg) according to the maximum received dose of prednisolone during their treatment. The response and recurrence rate between two groups were compared.Results: 108 patients were included in this study. Totally, 84.3% of patients responded to corticosteroids: 82.5% in the high dose group and 85.3% in low dose group (P-value=0.7). Total recurrence was 21.9% in all patients. 21.7% of patients in high dose group and 22% of patients in low dose experienced recurrence(P-value=0.984). Conclusion: Our study suggests that lower safe doses of corticosteroids may be used to treat IGM patients without influencing the treatment efficacy. Prospective randomized trials with larger sample sizes and matched case-control groups are necessary to further clarify this issue.
- 13 April 2022
- Published by Springer Nature in Research Square
Open AccessComparison of high- and low-dose prednisolone in the treatment of idiopathic granulomatous mastitis: a retrospective study
Background:There is no consensus regarding best treatment for Idiopathic granulomatous mastitis(IGM). Regarding the inflammatory entity of this disease, corticosteroids have been used with good results. However, prescribing lower dosages are more appealing, regarding their side effects. The aim of this study is to compare the response and recurrence rates in IGM patients treated with low dose and high dose prednisolone.Methods: Medical records of patients diagnosed with IGM in the Cancer Institute and Arash Women's Hospital hospital of Tehran University of Medical Sciences from November 2012 to December 2020 were evaluated retrospectively. Patients with first presentation of disease who had been treated with oral prednisolone were included, and were classified as low dose group(less than 25mg) and high dose group(equal or more than 25mg) according to the maximum received dose of prednisolone during their treatment. The response and recurrence rate between two groups were compared.Results: 108 patients were included in this study. Totally, 84.3% of patients responded to corticosteroids: 82.5% in the high dose group and 85.3% in low dose group (P-value=0.7). Total recurrence was 21.9% in all patients. 21.7% of patients in high dose group and 22% of patients in low dose experienced recurrence(P-value=0.984). Conclusion: Our study suggests that lower safe doses of corticosteroids may be used to treat IGM patients without influencing the treatment efficacy. Prospective randomized trials with larger sample sizes and matched case-control groups are necessary to further clarify this issue.
- Open Access
- 1 December 2021
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 24 (12) , 881-886
Role of Tumor Subtypes in Response to Neoadjuvant Chemotherapy in Non-metastatic Breast Cancer
Background: Neoadjuvant chemotherapy (NAC) is an integral part of breast cancer treatment. Determination of the factors that can distinguish patients who will have best response to NAC is invaluable. In this study, we aimed to elucidate the factors influencing patient response to NAC. Methods: We retrospectively collected data of female patients with non-metastatic breast cancer that had received NAC followed by surgery, admitted to Imam Khomeini hospital between 2015–2019. We investigated the association between various tumor and patients’ characteristics with pathologic complete response (PCR). Results: Overall data of 205 female patients were collected. PCR was observed in 27.6% of cases. PCR rate in luminal A, luminal B, HER2 enriched, and TNB tumors was reported in 11.1%, 30.2%, 35.7%, and 36.4% of patients respectively (P=0.27). In patients with luminal B tumors, PCR was more prevalent in patients with positive HER2 only (P=0.006). In our study factors which was significantly associated with PCR were: tumor grade, progesterone receptor (PR) status, and HER2 status. In the multiple regression model, positive PR in the tumor lowered the odds of pathologic response 3.6 times (P=0.004). Conclusion: In our study, tumor grade, PR status, and HER2 status was associated with response to NAC. PCR was more prevalent in non-luminal tumors; however, PCR rate in luminal B patients-especially those with HER2 positive status- was slightly less than non-luminals.
- 1 December 2021
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 24 (12) , 881-886
Open AccessRole of Tumor Subtypes in Response to Neoadjuvant Chemotherapy in Non-metastatic Breast Cancer
Background: Neoadjuvant chemotherapy (NAC) is an integral part of breast cancer treatment. Determination of the factors that can distinguish patients who will have best response to NAC is invaluable. In this study, we aimed to elucidate the factors influencing patient response to NAC. Methods: We retrospectively collected data of female patients with non-metastatic breast cancer that had received NAC followed by surgery, admitted to Imam Khomeini hospital between 2015–2019. We investigated the association between various tumor and patients’ characteristics with pathologic complete response (PCR). Results: Overall data of 205 female patients were collected. PCR was observed in 27.6% of cases. PCR rate in luminal A, luminal B, HER2 enriched, and TNB tumors was reported in 11.1%, 30.2%, 35.7%, and 36.4% of patients respectively (P=0.27). In patients with luminal B tumors, PCR was more prevalent in patients with positive HER2 only (P=0.006). In our study factors which was significantly associated with PCR were: tumor grade, progesterone receptor (PR) status, and HER2 status. In the multiple regression model, positive PR in the tumor lowered the odds of pathologic response 3.6 times (P=0.004). Conclusion: In our study, tumor grade, PR status, and HER2 status was associated with response to NAC. PCR was more prevalent in non-luminal tumors; however, PCR rate in luminal B patients-especially those with HER2 positive status- was slightly less than non-luminals.
- Open Access
- 18 January 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (3) , 1433-1437
Solitary metastases of lower extremity myxoid liposarcoma to breast: A case report and review of literature
Solitary breast metastases from myxoid liposarcoma are extremely rare. Resection with negative margins seems as an effective treatment leading to improved survival.
- 18 January 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (3) , 1433-1437
Open AccessSolitary metastases of lower extremity myxoid liposarcoma to breast: A case report and review of literature
Solitary breast metastases from myxoid liposarcoma are extremely rare. Resection with negative margins seems as an effective treatment leading to improved survival.
- Open Access
- 1 November 2012
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 94 (8) , e20-e22
Ectopic Cushing’s syndrome due to a mesenteric neuroendocrine tumour
INTRODUCTION: Neuroendocrine tumours (NETs) are tumours that commonly involve the gastrointestinal system. Common primary sites in the gastrointestinal system include the small intestine, appendix, rectum and pancreas. Mesenteric NETs are extremely rare entities and are sparsely reported in the literature. CASE HISTORY: We report the case of a 62-year-old woman with ectopic Cushing’s syndrome due to excessive adrenocorticotropic hormone secretion by a primary mesenteric tumour in the small intestine and its liver metastases. CONCLUSIONS: Although rare, the mesentery can be a primary site for NETs. It can cause similar symptoms and require similar treatment options. Tumour resection and debulking are acceptable ways to improve both the survival and symptoms.
- 1 November 2012
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 94 (8) , e20-e22
Open AccessEctopic Cushing’s syndrome due to a mesenteric neuroendocrine tumour
INTRODUCTION: Neuroendocrine tumours (NETs) are tumours that commonly involve the gastrointestinal system. Common primary sites in the gastrointestinal system include the small intestine, appendix, rectum and pancreas. Mesenteric NETs are extremely rare entities and are sparsely reported in the literature. CASE HISTORY: We report the case of a 62-year-old woman with ectopic Cushing’s syndrome due to excessive adrenocorticotropic hormone secretion by a primary mesenteric tumour in the small intestine and its liver metastases. CONCLUSIONS: Although rare, the mesentery can be a primary site for NETs. It can cause similar symptoms and require similar treatment options. Tumour resection and debulking are acceptable ways to improve both the survival and symptoms.